Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1998-02-26
2000-09-19
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514560, 514577, 514597, A61K 3120, A61K 31185, A61K 3117
Patent
active
061213209
ABSTRACT:
A method of treating leukemia which includes administering an effective amount of composition comprising suramin and a biological response modifier, wherein the suramin and the biological response modifier show synergistic or additive anti-leukemic activity. A pharmaceutical composition is also disclosed.
REFERENCES:
patent: 4232150 (1980-11-01), Nair et al.
patent: 4266077 (1981-05-01), Conrow et al.
patent: 4304903 (1981-12-01), Nair et al.
patent: 4371524 (1983-02-01), Shinohara et al.
patent: 4387059 (1983-06-01), Conrow et al.
patent: 4393055 (1983-07-01), Nair et al.
patent: 4407796 (1983-10-01), Miner et al.
patent: 4414207 (1983-11-01), Nair et al.
patent: 4459293 (1984-07-01), Miner et al.
patent: 4591604 (1986-05-01), Conrow et al.
patent: 5158940 (1992-10-01), LaRocca et al.
patent: 5585243 (1996-12-01), Aster et al.
R. Lopez et al., "The Synergistic and Antagonistic Effects of Cytotoxic and Biological Agents on the In Vitro Antitumour Effects of Suramin", European Journal of Cancer, vol. 30A, No. 10, 1994, pp. 1545-1549.
A. Falcone et al., "Synergistic Antiproliferative Activity of Suramin and .alpha.2A-Interferon Against Human Colorectal Adenocarcinoma Cell Lines: In vitro Studies", European Journal of Cancer, vol. 30A, No. 4, 1994, pp. 516-520.
Michael Doukas et al., "Inhibition of granulocyte-macrophage colony-stimulating factor (GM-CSF) activity by suramin and suramin analogs is correlated to interaction with the GM-CSF nucleotide-binding site", 21284q, Chemical Abstracts 1 -Pharmacology, vol. 124, No. 3, 1996, p. 57. Abstract Only.
Emmanuel Roilides et al., "Suppression of polymorphonuclear leukocyte bactericidal activity by suramin", 204843s, Chemical Abstracts, vol. 118, 1993, p. 36. Abstract Only.
Krystyna Gnacinska et al., "Block of the macrophage system and blood lipids", 88004n, 1-Pharmacodynamics, vol. 92, 1980, p. 35. Abstract Only.
V. Dimov et al., "Phagocytic and candidacidal activity of alveolar macrophages from suramin-treated mice", 48367f, Chemical Abstracts, vol. 101, 1984, pp. 38. Abstract Only.
P. Draper, "Effects of anionic inhibitors of phagosome-lysosome fusion in cultured macrophages when the ingested organism is Mycobacterium lepraemurium", 54457b, Chemical Abstracts, vol. 91, 1997, p. 506. Abstract Only.
Edward L. Pesanti, "Suramin effects on macrophage phagolysosome formation and antimicrobial activity", 84580n, Chemical Abstracts, vol. 89, 1978, p. 16. Abstract Only.
V. Dimov et al., "Influence of suramin and cyclophoshamide administered in combination on alveolar macrophages", 185492m, Chemical Abstracts, vol. 100, 1984, p. 34. Abstract Only.
M. K. Pratten, "Effect of suramin on pinocytosis by resident rate peritoneal macrophages: an analysis using four difference substrates", 114605q, Chemical Abstracts, vol. 100, 1984, p. 22. Abstract Only.
Glenn A. Warr et al., "Lung macrophage defense responses during suramin-induced lysosomal dysfunction", 215t, 1-Pharmacology, vol. 99, 1983, p. 221. Abstract Only.
Hong Xiang Zhang et al., "Modulation by suramin of NK and monocytic cell-mediated cytotoxicity in human and murine cells", 221980r, Chemical Abstracts, vol. 109, 1998, pp. 24-25. Abstract Only.
S. Trifonov, et al., "Activation of chicken peritoneal macrophages by suramin", 198002s, 1-Pharmacology, vol. 108, 1988, p. 33. Abstract Only.
R. Toshkova et al., "Immunoprotective and immunomodulating activities of suramin in hamsters with myeloid tumor, induced by Graffi virus", 246203s, Chemical Abstracts, vol. 23, 1995, p. 42. Abstract Only.
C. Schiller et al., "Influence of suramin on the expression of Fc receptors and other markers on human monocytes and U937 cells, and on their phagocytic properties", 99107s, 1-Pharmacology, vol. 121, 1994, pp. 27-28. Abstract Only.
R. LaRocca et al., "Use of suramin to treat rheumatologic diseases", 64775g, 1-Pharmacology, vol. 115, 1991, p. 101. Abstract Only.
P. Novales-Li, "In vitro immunopharmacologic effect of suramin on modifying Th-subset cytokine levels in splenocytes and T-cell clones: a therapeutic application for autoimmune disease", 158032w, Chemical Abstracts 1-Pharmacology, vol. 125, No. 13, 1996, p. 68 Abstract Only.
M Doukas et al., "Suramin and suramin analog activity against leukemic cell lines: Correlation to interaction with the granulocyte/macrophage colony stimulating factor nucleotide-binding site", Experimental Therapeutics #2037, Proceedings of the American Association for Cancer Research, vol. 37, Mar. 1996, pp. 299-300. Abstract Only.
Nakashima et al., Med. Microbiol. Immunol., 176(4), 189-98 Abstract Only 1987.
Breitman et al., Proc. Natl. Acad. Sci. U.S.A., 77950, 2936-40 Abstract Only 1980.
Doukas et al., #2036, Proc. Am. Assoc. for Cancer Research, vol. 37 Mar. 1996.
Goldberg Jerome D.
The University of Kentucky Research Foundation
LandOfFree
Combination anti-leukemic therapy by utilizing suramin and biolo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination anti-leukemic therapy by utilizing suramin and biolo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination anti-leukemic therapy by utilizing suramin and biolo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073755